Radiomodulatory and antioxidant properties of a novel pyrazine-linked quinazolinone sulfonamide derivative: Insights into renal apoptosis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-06 · 399 (9) · 14109-14122
DOI: 10.1007/s00210-026-05248-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 09.04.2026. Verfasst von Heba M Karam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, 11787, Eg…. Hauptthemen laut MEDLINE: Sulfonamides, Antioxidants, Quinazolinones, Kidney. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Atomic Energy Authority.
Abstract (Originalsprache)
Quinazolinone derivatives possess a privileged scaffold with variable pharmacological activities. This study conducted an in vitro evaluation of the pyrazine-linked quinazolinone sulfonamide derivative ( PQS ) to assess its anticancer activity, following confirmation of its safety in a normal cell line. Results revealed that PQS has a noteworthy cytotoxic effect on HepG-2 and HeLa cells, indicating its potential anticancer activity. Additionally, PQS is quite safe on normal Vero cells. Furthermore, in vivo biological activity of PQS was evaluated for its radioprotective properties in (5 Gy) irradiated mice. PQS showed mitigation of gamma radiation-induced oxidative stress, verified by the decline in MDA, ROS and NO levels, while GSH levels and GST activities were improved in kidney tissues. The apoptotic pathway was also assessed, where weak expression of caspase-3 and Bcl2-associated X protein (Bax) was noticed paired with higher expression of B-cell lymphoma 2 (Bcl2) after PQS treatment in irradiated mice. These results were confirmed by histopathological examination of kidney tissues. Besides, in-silico ADME studies revealed that compound PQS showed drug-like properties, confirmed by its physicochemical and pharmacokinetic properties. In conclusion, the results of the present study demonstrated that PQS has dual activity as a potential anticancer on HepG-2 and HeLa cancer cell lines and radio-protective activity through its anti-apoptotic and antioxidant action in the in vivo study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, 11787, Egypt.
- Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, 11787, Egypt. Aiten_mahmoud@yahoo.com.
Förderung
- Egyptian Atomic Energy Authority
Zitieren
APA
Karam, H. M., Mekkawy, M. H., Abd-ElRaouf, A., Soliman, A. M., & Ghorab, M. M. (2026). Radiomodulatory and antioxidant properties of a novel pyrazine-linked quinazolinone sulfonamide derivative: Insights into renal apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(9), 14109-14122. https://doi.org/10.1007/s00210-026-05248-2
Vancouver
Karam HM, Mekkawy MH, Abd-ElRaouf A, Soliman AM, Ghorab MM. Radiomodulatory and antioxidant properties of a novel pyrazine-linked quinazolinone sulfonamide derivative: Insights into renal apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(9):14109-14122. doi:10.1007/s00210-026-05248-2
BibTeX
@article{Karam2026,
author = {Karam, Heba M and Mekkawy, Mai H and Abd-ElRaouf, Amira and Soliman, Aiten M and Ghorab, Mostafa M},
title = {Radiomodulatory and antioxidant properties of a novel pyrazine-linked quinazolinone sulfonamide derivative: Insights into renal apoptosis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
volume = {399},
number = {9},
pages = {14109--14122},
doi = {10.1007/s00210-026-05248-2}
}
EUVIMED